Lexaria Bioscience Warrant
LEXXW
LEXXW was delisted on the 13th of January, 2026.
5 hedge funds and large institutions have $134K invested in Lexaria Bioscience Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 3 reducing their positions, and closing their positions.
7% more capital invested
Capital invested by funds: $125K → $134K (+$8.57K)
0% more funds holding
Funds holding: 5 → 5 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$7.23K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.27K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$60 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $78.9K | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $42K | -$7.23K | -30,227 | -13% |
|
|
CH
3
CVI Holdings
Wilmington,
Delaware
| $8.82K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $4.17K | -$1.27K | -5,294 | -21% |
|
|
5
UBS Group
Zurich,
Switzerland
| $24 | -$60 | -251 | -67% |
|
LEXXW Hedge Fund Activity: Q3 2023 in Review
5 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience Warrant (LEXXW) for Q3 2023, worth a combined $134K — up 6.8% from $125K a quarter earlier.
Fund positioning in LEXXW was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.
The largest seller was Sabby Management, cutting an estimated $7.23K.
- 5 institutional investors held Lexaria Bioscience Warrant (LEXXW) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $134K of Lexaria Bioscience Warrant stock for Q3 2023, up 6.8% quarter-over-quarter.
- 0 funds opened new Lexaria Bioscience Warrant positions in Q3 2023 and 0 closed out.
- The largest Lexaria Bioscience Warrant seller in Q3 2023 was Sabby Management, an estimated $7.23K sold.
Based on aggregated 13F filings for Q3 2023.